Our technology

Building Transformative Therapeutics Through Simulation

The unparalleled accuracy of our technology grants unprecedented insights into drug mechanisms, allowing us and our partners to pursue truly groundbreaking therapeutic strategies.

Learn More

Our Mission

Unlocking Undruggable Targets

Our core technology has been built to succeed where status quo in-silico drug design fails. We’ve raised the bar for simulation accuracy, putting previously inaccessible targets and modalities into play.

About Us

Recent News & Events

June 3, 2025

We are excited to announce our CEO, Dr. Anthony Fejes will take the stage at the BIOTECanada Coast-to-Coast competition at BIO 2025, on Wednesday, June 18 at 10AM in Boston. This unique event highlights five promising biotech companies from across Canada, each delivering a focused, no-slide pitch to a panel of leading investors and pharma executives.

May 16, 2025

CEO, Dr. Anthony Fejes, will be presenting at the Pitch Competition taking place on May 29 in the BC Pavilion at Web Summit Vancouver. Please join us, along with thousands of international entrepreneurs, investors, media and leaders in an event to connect the tech world.

May 7, 2025

Our CEO, Dr. Anthony Fejes, and Director of Business Development, Mr. Jacek Mis, will be in Boston, June 16-19 at the 2025 BIO International Convention. Connect with us through the partnering portal or email us directly to learn about our technology and its drug discovery potential.

View All News & Events
Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions